BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Trials

Australian researchers lead world in successful trial of new cancer treatment

Relatlimab is the first immunotherapy treatment to target LAG-3, a protein in immune cells which reinvigorates and enhances the tumour fighting r...

June 07, 2021 | News

Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™

ASCO 2021, which celebrates its 57th anniversary this year, runs from June 4th to June 8th and will be held virtually due to COVID-19. Some ...

June 07, 2021 | News

Vela Diagnostics Collaboration with the NCCS to Refine Novel Cancer Therapy

Being able to predict an individual's response will help clinicians determine if EGFR-TKIs are a suitable therapeutic option for the patient. The partnersh...

June 04, 2021 | News

21% were not aware Australian data is accepted by the FDA and other major regulatory authorities

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results o...

June 04, 2021 | Analysis

Akoya launches Advanced Biopharma Solutions

Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced the launch of Advanced Biopharma Solutions (ABS) as a premium serv...

June 03, 2021 | News

BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® Biosimilar

First clinical trial from BioFactura’s pipeline of high-value biosimilar and biodefense drugs BFI-751: Biosimilar designed to treat people with Cr...

June 01, 2021 | News

Liminal BioSciences Update Clinical Activities for Fezagepras

Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that bas...

May 31, 2021 | News

Vietnam's Coronavirus immunization set to start stage 3 preliminaries in June

This follows promising outcomes found in the initial two stages. The Public Morals Council in Biomedical Exploration under the Service of Wellbein...

May 29, 2021 | News

Gannex Received China IND Approval

Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-...

May 28, 2021 | News

Boehringer Ingelheim's Receives FDA Breakthrough for CONNEX trial program

BI 425809, A Novel Glycine transporter-1 (GlyT1) Inhibitor To Be Studied in First-of-its-Kind Phase III Trials, Incorporating Speech Analytics and Virtual ...

May 25, 2021 | News

Agilex Biolabs Partners with Endpoints News for Clinical Trials

Agilex Biolabs' Director, Immunoassay, Kurt J. Sales (B.Sc; B.Sc (MED) Hons; M.Sc, Ph.D, PGCM) said:"Inflammation is a complex biological process involving...

May 21, 2021 | News

Achiko completes initial shipment of AptameX to Indonesia

Production of first 1,000 AptameX test kits is concluded in Singapore (initial capacity to test 10,000 patients per day). AptameX delivers sensitivity o...

May 20, 2021 | News

Nanoform’s final clinical results confirm value proposition to the pharma industry

Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced the completion and final results of its clinical s...

May 18, 2021 | News

Sanofi and GSK COVID-19 vaccine shows strong immunity in all age variants

Adjuvanted recombinant COVID-19 vaccine candidate triggered strong neutralizing antibody responses in all adult age groups High immune response after a ...

May 17, 2021 | News

Stay Connected